Our platform unites the intersection of biology, computation, and finance

The Hub-and-spoke model

Enables us to spin out assets into subsidiaries to create a distributed portfolio on mitigated risk

We operate across London, Cambridge, and New York

OUR LABS
Computational Lab
Medius House,
2 Sheraton Street,
London W1F 8BH
Experimental Lab
Milner Therapeutics Institute,
Jeffrey Cheah Biomedical Centre,
Puddicombe Way,
Cambridge, CB2 0AW

Pipeline

Target ID
Hit to Lead
Lead Op
IND
Clinical trials
Best in class
First in class
Our first drug programme aims to generate a best-in-class asset to help millions of patients with neurological diseases.
Our second programme aims to generate a first-in-class asset to treat a universally fatal brain disease.
A science first company creating  a step change in the way drugs are developed.
Lorem ipsum dolor sit amet consectetur. Pharetra phasellus suscipit dolor justo arcu a nibh volutpat ornare. Parturient at ridiculus turpis pharetra cras. Enim arcu ullamcorper massa in vel faucibus arcu. Turpis duis ullamcorper venenatis ut faucibus.

Amet proin sit mauris tellus feugiat viverra pretium nunc varius. Egestas interdum rhoncus quam vel ut. Elit mi netus nec ut turpis aliquam nisi.
Polly
Lorem ipsum dolor sit amet consectetur. Pharetra phasellus suscipit dolor justo arcu a nibh volutpat ornare. Parturient at ridiculus turpis pharetra cras.
Lauren
Hi Polly, what do you make of this issue?
Pipeline
Lorem ipsum dolor sit amet consectetur. Pharetra phasellus suscipit dolor justo arcu a nibh volutpat ornare. Parturient at ridiculus turpis pharetra cras. Enim arcu ullamcorper massa in vel faucibus arcu. Turpis duis ullamcorper venenatis ut faucibus.Amet proin sit mauris tellus feugiat viverra pretium nunc varius. Egestas interdum rhoncus quam vel ut. Elit mi netus nec ut turpis aliquam nisi.
Lorem ipsum dolor sit amet consectetur. Pharetra phasellus suscipit dolor justo arcu a nibh volutpat ornare. Parturient at ridiculus turpis pharetra cras. Enim arcu ullamcorper massa in vel faucibus arcu. Turpis duis ullamcorper venenatis ut faucibus.Amet proin sit mauris tellus feugiat viverra pretium nunc varius. Egestas interdum rhoncus quam vel ut. Elit mi netus nec ut turpis aliquam nisi.